Drug application
GLYCOPREP (POLYETHYLENE GLYCOL 3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE and 2 more)
Drugs@FDA ANDA 072319 · GOLDLINE
Key facts
| Drug name | GLYCOPREP |
|---|---|
| Active ingredients | POLYETHYLENE GLYCOL 3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE, SODIUM SULFATE ANHYDROUS |
| Application type | ANDA |
| Application number | 072319 |
| Company | GOLDLINE |
| Dosage forms | FOR SUSPENSION, ORAL |
| Strength | 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Dec 23, 1988 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.